gilead

Gilead Is Profiteering Off A COVID Drug We Already Paid For The American public helped finance the development of remdesivir — and will now be charged $3,000 for a treatment that experts say costs less than $10 to produce. This is a story of cause and effect — a tale of repeated and calculated...